Who invested in Innate Pharma?
Innate Pharma's investors include Sofinnova Partners, Auriga Partners, Gimv, Ardian and Akka Venture, and 6 more on record.

France · Funded startup
Funding summaryUpdated 26 Oct 2026
$134Mraised across 5 rounds since 2000, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
Reported by biospace.comSEC filing: $27M sold, first sale Nov 2013
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Innate Pharma's investors include Sofinnova Partners, Auriga Partners, Gimv, Ardian and Akka Venture, and 6 more on record.
Innate Pharma has raised $134M across 5 rounds since 2000.
Innate Pharma's most recent round was an Undisclosed round of $68M in Jun 2014.
Its most recent round, $68M in Jun 2014, is also its largest on record.
Innate Pharma's first round on record, in Mar 2000, was backed by Sofinnova Partners, Auriga Partners and Gimv.
Innate Pharma's latest named round is an Undisclosed round, in Jun 2014.
Innate Pharma is based in France.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.